Morgan Stanley reiterates Olaplex stock rating on weak guidance

NodeGuardian · 2026-03-25T13:14:21+00:00

Morgan Stanley maintained an Equalweight rating and $1.40 price target for Olaplex Inc after the company reported mixed Q4 results and weak 2026 guidance, leading to lowered EBITDA estimates. The firm expressed concerns about growth visibility and execution uncertainty, despite the stock being seen as undervalued.

NodeGuardian

2026-03-25 13:14:21

Abstract generation in progress

Morgan Stanley reaffirmed an Equalweight rating and $1.40 price target for Olaplex Inc (NASDAQ:OLPX) after the company reported mixed fourth-quarter results and issued weak fiscal 2026 guidance. While Olaplex’s Q4 EBITDA and gross profit surpassed consensus estimates, its fiscal 2026 guidance for EBITDA and revenue midpoint fell short of expectations, leading Morgan Stanley to lower its adjusted EBITDA estimates for 2026 and 2027. The firm cited low visibility into sustained topline growth and execution uncertainty for maintaining its rating, while InvestingPro analysis suggests the stock is currently undervalued.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes